Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 9/20 | 0.39 |
| ▸ | METAP1 | P53582 | 2/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MITF | O75030 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23914077 | 1.00 | CHRNA7 (0.39) | CHRNA7METAP1CHRM5ADRA2CCHRM2 | |
| SCHEMBL14534416 | 0.70 | POLB (0.32) | POLB | |
| SCHEMBL23914414 | 0.69 | ALDH1A1 (0.51) | MEN1POLBKMT2AKDM4EALDH1A1 | |
| SCHEMBL23913784 | 0.69 | CHRNA7 (0.47) | CHRNA7METAP1ADRA2CLMNA | |
| SCHEMBL12014397 | 0.68 | ADRA2C (0.41) | CHRNA7METAP1CHRM5ADRA2C | |
| SCHEMBL65466 | 0.66 | METAP1 (0.38) | CHRNA7METAP1CHRM5ADRA2C | |
| Pimeclone SCHEMBL545058 | 0.66 | CHRM5 (0.47) | CHRNA7METAP1CHRM5ADRA2CKMT2A | |
| SCHEMBL13609489 | 0.65 | CHRNA7 (0.47) | CHRNA7METAP1CHRM5ADRA2C | |
| Pimeclone SCHEMBL4551919 | 0.65 | CHRM5 (0.45) | CHRNA7METAP1CHRM5ADRA2CKMT2A | |
| SCHEMBL12949415 | 0.64 | CHRM5 (0.43) | CHRNA7METAP1CHRM5ADRA2CKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | MIF, LTA, MGAM | CHRNA7 4821/4885METAP1 890/4885CHRM5 4403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.